Company Invitrocue Limited

Invitrocue Limited is engaged in research and experimental development on biotechnology, life and medical science. The Company offers a three dimension (3D) cell-based scaffolding technology, which mimics a human for Tropical Diseases to investigate the lifecycle of Plasmodium cynomolgi (monkey malaria) and helps in evaluating new drug targets to malaria infection using in vitro hepatocyte culture systems. It is engaged in developing non-small cell lung cancer organoids and for drug testing programs using approved drugs. It is also engaged in range of activities, including in vitro cell-based assays, patient-derived organoids, digital pathology and medical imaging, while providing access to industry networks. It also offers an in vitro screening of experimental drug compounds for anti-leishmanial activity. It intends to develop an in vitro 3D perfused liver model to expedite and facilitate new application notes in infectious liver diseases.